Insider · CIK 0001563420

Lederman Seth

CIK 0001563420 Name as filed on the most recent filing

Filed as Lederman Seth (38)

46 transaction lines · from 38 filings · filed 2013-05-20 to 2026-06-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

46 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-09 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 58,950, acquired Open Form 4 filing 0001493152-26-027986
2026-03-31 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 63,100, acquired Open Form 4 filing 0001999371-26-007447
2026-03-18 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 223,350, acquired Open Form 4 filing 0001999371-26-006235
2025-05-15 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 86,200, acquired Open Form 4 filing 0001999371-25-006261
2022-06-29 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 34,200, acquired Open Form 4 filing 0001387131-22-007441
2022-03-25 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 24,500, acquired Open Form 4 filing 0001387131-22-003991
2021-09-28 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 7,320, acquired Open Form 4 filing 0001387131-21-009696
2021-03-24 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 22,088, acquired Open Form 4 filing 0001387131-21-003875
2020-12-30 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 23,800, acquired Open Form 4 filing 0001387131-21-000041
2020-08-13 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 54,600, acquired Open Form 4 filing 0001387131-20-007592
2019-12-03 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 23,180, acquired Open Form 4 filing 0001387131-19-009327
2019-03-29 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 12,440, acquired Open Form 4 filing 0001387131-19-002339
2019-03-26 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 59,375, acquired Open Form 4 filing 0001387131-19-002230
2018-06-29 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 2,320, acquired Open Form 4 filing 0001615774-18-006088
2018-06-28 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 2,290, acquired Open Form 4 filing 0001615774-18-006006
2018-06-27 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 2,275, acquired Open Form 4 filing 0001615774-18-005896
2018-06-12 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 2 lines 13,110, acquired Open Form 4 filing 0001615774-18-005290
2018-05-25 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 12,680, acquired Open Form 4 filing 0001615774-18-004510
2017-12-26 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 19,133, acquired Open Form 4 filing 0001615774-17-007619
2017-08-17 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 45,068, acquired Open Form 4 filing 0001615774-17-004563
2017-08-16 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 14,950, acquired Open Form 4 filing 0001615774-17-004563
2017-06-30 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 21,640, acquired Open Form 4 filing 0001615774-17-003457
2017-06-26 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 22,000, acquired Open Form 4 filing 0001615774-17-003376
2017-06-20 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 84,400, acquired Open Form 4 filing 0001615774-17-003262
2016-11-21 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 41,924, acquired Open Form 4 filing 0001615774-16-008539
2016-10-31 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP Not reported Open Form 4 filing 0001615774-16-007912
2016-06-22 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 41,500, acquired Open Form 4 filing 0001615774-16-006035
2016-06-21 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 50,000, acquired Open Form 4 filing 0001615774-16-005996
2016-03-23 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 19,537, acquired Open Form 4 filing 0001144204-16-089880
2015-09-25 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 39,000, acquired Open Form 4 filing 0001144204-15-056504
2015-07-17 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 45,000, acquired Open Form 4 filing 0001144204-15-043102
2015-03-17 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 7,180, acquired Open Form 4 filing 0001144204-15-016666
2015-03-16 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 6,853, acquired Open Form 4 filing 0001144204-15-016666
2015-03-13 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 7,210, acquired Open Form 4 filing 0001144204-15-015878
2015-03-12 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 7,260, acquired Open Form 4 filing 0001144204-15-015878
2015-03-11 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 7,000, acquired Open Form 4 filing 0001144204-15-015317
2015-03-10 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 6,900, acquired Open Form 4 filing 0001144204-15-015317
2015-03-09 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 6,500, acquired Open Form 4 filing 0001144204-15-014740
2015-03-06 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 6,450, acquired Open Form 4 filing 0001144204-15-014740
2015-03-05 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 6,480, acquired Open Form 4 filing 0001144204-15-014339
2015-03-04 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 6,050, acquired Open Form 4 filing 0001144204-15-014339
2015-02-09 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 29,250, acquired Open Form 4 filing 0001144204-15-007164
2013-08-14 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP Not reported Open Form 4 filing 0001144204-13-046276
2013-05-20 P, Open-market purchase Tonix Pharmaceuticals Holding Corp.TNXP 2 lines 7,300, acquired Open Form 4 filing 0001144204-13-030431

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 46
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. LEDERMAN SETH, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001563420

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.